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Purpose: Despite ubiquitous expression of the keratoepithelin (KE) protein encoded by the transforming growth factor
beta induced/beta induced gene human clone 3 (TGFBI/BIGH3) gene, corneal dystrophies are restricted to the cornea,
and no other tissues are affected. We investigated the role of TGFBI/BIGH3 in Groenouw corneal dystrophies by
generating transgenic mice overexpressing TGFBI/BIGH3 containing the R555W mutation.
Methods: Transgenic animals expressing the Groenouw mutation of human TGFBI/BIGH3 were generated using lentiviral
vectors. The line expressed TGFBI/BIGH3 containing the R555W mutation under the control of the phosphoglycerate
kinase (PGK) promoter. Expression of the transgene was monitored by Southern and western blotting and by RT–PCR.
Electroretinogram analysis was performed and four mice were subjected to complete necroscopy.
Results: Transgene expression was observed in different organs although without specific expression in the cornea. The
overall morphology of the transgenic animals was not severely affected by KE overexpression. However, we observed an
age-dependent retinal degeneration both functionally and histologically. Female-specific follicular hyperplasia in the
spleen and increased levels of lipofuscin in the adrenal gland were also seen in transgenic animals.
Conclusions: Cellular degeneration in the retina of transgenic animals suggest that perturbation of the transforming growth
factor beta (TGFβ) family regulation may affect photoreceptor survival and may induce possible accelerated aging in
several tissues. No corneal phenotype could be observed, probably due to the lack of transgene expression in this tissue.
Human corneal dystrophies (HCD) are rare hereditary
diseases characterized by bilateral loss of corneal
transparency due to the slow accumulation of amyloid as well
as non-amyloid deposits. Symptoms may become present as
early as birth, but more frequently they develop during
adolescence and gradually progress throughout life. We and
others have mapped four different forms of HCD to
chromosome 5q31 [1] and subsequently recognized that
mutations in the transforming growth factor beta-induced
gene (TGFBI/BIGH3) were the causes of these diseases [2].
Although mutations at two specific amino acids (R124 and
R555) are responsible for the great majority of the cases,
isolated families have been described with mutations in other
parts of the gene [3,4].
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Studies of TGFBI/BIGH3-related HCD are of great
interest, and while keratoepithelin (KE), the product of
TGFBI/BIGH3, is ubiquitously expressed except in the brain,
it is still not understood why KE deposits only occur in corneas
[5]. In this report, we describe a transgenic mouse line
expressing an R555W mutated form of human TGFBI/BIGH3
in an attempt to generate a model for the Groenouw type I
HCD. Extensive postmortem analyses included macroscopic
and histopathologic analyses of organs and measures of the
principal metabolic enzymes. Our data indicate that transgene
expression of TGFBI/BIGH3 induced an age-dependent
retinal degeneration, associated with concomitant
significantly attenuated cone and rod responses. Female
animals also displayed a mild follicular hyperplasia in the
spleen and lipofuscin expression in the adrenal glands,
suggesting an accelerated aging process. No other
histopathologic abnormalities were noticed in the transgenic
animals compared to control mice. In particular, no transgenic
RNA expression was observed in the corneas of these animals.
MATERIAL AND METHODS
Lentivirus generation: Recombinant lentiviral particles
containing a vesicular stomatitis virus G protein (VSV-G)
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envelop were produced by transient transfection of 293T cells
as previously described [6]. Briefly, 293T cells were
transfected with the different plasmids using calcium
phosphate, the medium harvested 36 h later and centrifuged
at 70,000x g. Viral supernatants were concentrated by a
second ultracentrifugation at 70,000x g for 90 min at 4 °C.
The viral pellets were resuspended in a minimal of volume of
PBS containing 10 mg/ml bovine serum albumin (BSA).
Aliquots of 5 µl were then stored at −70 °C until further use.
Total particle concentration of the viral stocks was estimated
by quantification of the p24 capsid protein using Retro-TEK
HIV-1 p24 Antigen ELISA kit (ZeptoMetrixCorporation,
Buffalo, New York).
High transduction efficiency was observed in corneal
endothelial cells in vivo, using an HIV-1-derived lentivirus
with a cytomegalovirus immediate early promoter (CMV). A
similar efficacy was reported for rat, ovine, and human cornea
explants infected in vitro with a lentiviral vector carrying a
simian virus (SV) promoter [7,8]. Previous results have shown
similar efficacy in mouse cornea using HIV or equine
infectious anemia virus (EIAV) vectors containing the vectors
containing the VSV-G envelop (VSVG) envelop and the
CMV vector [9]. In cell culture, EIAV has also shown a strong
efficiency to transduce human endothelial cells using a CMV
promoter and the VSV-G envelop [10].
A human TGFBI/BIGH3 cDNA with the R555W
Groenouw mutation was ligated into BamHI sites of a
replication-deficient, self-inactivating plasmid (pSIN) under
the regulation of the mouse phosphoglycerate kinase promoter
(PGK; Figure 1). The PGK promoter is a ubiquitous promoter
that was successfully used with lentiviral vectors in many
tissues [11,12]. Since the GC-rich sequence of the mouse PGK
promoter contains only three ATG triplets, this promoter is
particularly suitable for lentiviral constructions as compared
to other ubiquitous promoters [13]. Presence or absence of
mutation was confirmed by direct sequencing of the insert.
Lentiviral vector preparation: A replication-deficient, self-
inactivating (SIN) backbone was obtained from Patrick
Aebischer (Ecole Polytechnique Fédérale de Lausanne
[EPFL], Lausanne, Switzerland). The transgene encoding the
human TGFBI/BIGH3 cDNA was inserted into a backbone
containing the SIN followed by the elongation factor-1
Figure 1. Lentiviral backbone containing the phosphoglycerate
kinase promoter and the post-transcriptional regulatory element of
woodchuck hepatitis virus. Note the Groenouw (R555W) mutation,
the localization of the probe used for Southern blotting, and the
unique BamHI site (black arrow). In the figure, n indicates the
number of founders obtained for the construct.
minimum promoter and the woodchuck hepatitis post-
transcriptional regulatory elements (SIN-W-EFs) to generate
the lentiviral vector LV_BIGH3. The lentiviral vector was
produced as described above and previously by Naldini [14].
Generation of transgenic animals: All procedures implicating
mice manipulation were performed in agreement with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and were approved by the local Veterinary
Committee Office on Use and Care of Animals in Research
of Canton Vaud, Lausanne, Switzerland. Mice (120 total, 60
males and 60 females) were maintained on a 14:10 light-dark
cycle under standard housing conditions. Water and standard
high protein food (Kliba, Switzerland) were available at
libitum.
Transgenesis was performed according to standard
protocols [15]. Briefly, four-week-old National Marine
Research Institute (NMRI) females were superovulated by
intraperitoneal injection of 5U pregnant mare’s serum
gonadotropin followed by injection of 5U human chorionic
gonadotropin 48 h later. Superovulated females were mated
with NMRI males, and embryos were collected at zygote stage
on the following day. Zygotes were then immediately
microinjected into the perivitelline space with 10-100
picoliters of about 109 transduction unit/ml lentiviral
preparation and incubated in M16 medium (Sigma, St. Louis,
MO) at 37 °C and 5% CO2 atmosphere. On the following day,
two-cell stage embryos were selected and transferred into the
oviduct of 3 pseudopregnant NMRI females.
NMRI mice are widely used as experimental models in
many fields of general biology. Albino NMRI mice are widely
used in transgenesis since embryos derived from this strain
are more resistant than inbred mouse embryos such as C57/
BL6 and their use results in a higher transgenesis rate.
Moreover, outbred mice embryos are more resistant than
inbred mice embryos and lead to a higher transgenesis rate.
RNA extraction: Several organs including retina and cornea
were removed from euthanized mice and directly placed in
ice. Euthanasia was performed by neck dislocation. Total
RNA was extracted using Trizol® reagent according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA). RNA
concentration and purity were measured using RiboGreen®
(Molecular Probes, Eugene, OR) according to the
manufacturer’s instructions.
cDNA synthesis: Equal amounts (1 µg) of RNA were used to
synthesize cDNA using StrataScript Reverse Transcriptase
according to the manufacturer’s instructions (Stratagene, La
Jolla, CA).
Genomic DNA extraction: Genomic DNA was obtained from
mouse tail biopsies as follows: cut tail was transferred into
lysis buffer, which contained 100 mM TrisHCl, pH 8.5, 5 mM
EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 mM NaCl,
and 100 µg proteinase K/ml, and incubated in a rotating shaker
at 56 °C overnight. After complete lysis, samples were
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centrifuged for 2 min and the supernatant was transferred into
isopropanol. After a second 2 min centrifugation, supernatant
was removed and the pellet was dissolved in 150 µl 10 mM
TrisHCl and 0.1 mM EDTA, pH 7.5, and incubated at 80 °C
for 4 min. The obtained genomic DNA was directly used to
perform PCRs.
Transgene integration, expression, and monitoring:
Transgene integration was determined from biopsies by PCR
amplification of TGFBI/BIGH3. Genomic DNA (500 ng or 1
µg), obtained as described in the previous section, was
amplified. If not otherwise stated, the conditions were as
follows: a first incubation of 5 min at 94 °C, then 35 cycles of
1 min at 94 °C, 1 min at 56 °C and 3 min at 72 °C, and finally
a last extension of 10 min at 72 °C. The following primers
were used: Big-Big_F, Big-Big_R, PGK-BIG_F, and PGK-
BIG_R (Table 1). Since the human transgene sequence
contained a unique BamH1 site in a specific PCR-amplified
region, transgene transcription was monitored by digestion of
the PCR amplified cDNA produced by reverse-transcribed
RNA. PCR was performed from 100 to 500 ng cDNA
amplified by Hotstart Taq polymerase (Qiagen, Hilden,
Germany), with the primers 227F and 649R (Table 1) and the
following conditions: a first incubation of 5 min at 95 °C, then
30 cycles of 1 min at 95 °C, 1 min at 55 °C and 1 min at 72
°C, with a final extension of 10 min at 72 °C. BamHI digestion
was performed from 0.1 to 1 µg gel purified PCR product
incubated 8-16 h at 37 °C with 1 unit of enzyme in Roche B
buffer. Digestion of endogenous mouse TGFBI/BIGH3
resulted in a product of about 500 bp whereas BamHI
digestion of transgenic (human) TGFBI/BIGH3 resulted in
two bands of about 300 bp and 200 bp.
The number of transgene integration sites was monitored
by Southern blot. Genomic DNA obtained was digested with
EcoRI overnight at 37 °C. The digested DNA was precipitated
with 3M sodium acetate (pH 5.2)/EtOH on ice and
resuspended in trishydroxymethylaminomethane – ethylene
diamine tetraacetic acid (TE) buffer. A full-length TGFBI/
TABLE 1. LIST OF ALL THE PRIMERS USED IN THE GENERATION OF A TRANSGENIC MOUSE LINE.
Primer name 5'->3'
Big-Big_F AGTCATCAGCTACGAGTGCT
Big-Big_R CCCATTAGGATAGTGGTGG
PGK-BIG_F GATCCATCCAGGCGGCCGTG
PGK-BIG_R GAGGGTCATGCCGTGTTTCA
227F ACTTCACCAACTGCAAGCAG
649R TCTGGATGTTGGAATTCTGG
LTR1-biotin CTTAATACTGACGCTCTCGCACCA
LC1 GACCCGGGAGATCTGATTTC
LC2 GATCTGATTTCAGTGGCACAG
LC3 AGTGGCACAGCAGTTACG
LTR2 CACTGCTAGAGATTTTCCAC
LTR3 CCACACTGACTAAAAGGGTC
LTR4 GTCTGAGGGATCTCTAGTT
This table indicates the primers used in the different steps of
generating the transgenic mouse line. All the primers are
indicated in a 5'-3' direction and in triplet sets.
BIGH3 cDNA was radiolabeled with the random primed
technique and hybridized to the membrane. Hybridization was
performed with a probe from the vector’s backbone (Figure
1). Integration sites were also monitored by linear
amplification mediated polymerase chain reaction (LAM-
PCR) as described [16]. Briefly, a linear PCR with a long-
terminal repeat (LTR)-specific biotinylated primer (LTR1 in
Table 1) was performed. The specific amplified PCR products
were sorted by magnetic tag selection of extension primers. A
second DNA strand of each target sequence was synthesized
by random hexanucleotide priming. Double-stranded DNA
was digested with CfoI, and an asymmetric ligation cassette
was ligated to the end of CfoI-digested fragments. Nested
exponential PCR amplifications were then performed with
linker cassette (LC)-specific forward primers (LC primers,
Table 1) and LTR-specific reverse primers (LTR primers
Table 1). Primer pairs were LC1-LTR2, LC2-LTR3, and LC3-
LTR4. Finally, LAM-PCR products were subcloned in
pGEM-T easy vector, sequenced, and blasted against mouse
genomic DNA.
Protein extraction: Retina and cornea were removed from
dissected mouse eyes. Proteins were extracted and
homogenized for 10 min in 100 µl ice-cold RIPA buffer,
which consisted of 50 mM Tris-Cl pH 8.0, 150 mM NaCl, 1%
NP-40, 0.5% deoxycholate, and 0.1% SDS, and also contained
protease (Roche, Mannheim, Germany) and 1% phosphatase
(Sigma) inhibitor cocktails. Further homogenization through
a needle was performed when necessary. Retinas or corneas
were homogenized in ice-cold RIPA buffer with an 18 gauge
needle. Protein concentrations were measured by
bisinchoninic acid (BCA) protein assay (Pierce, Rockford,
IL).
Western blot analysis: Equal amounts of protein samples were
separated by 8% SDS–PAGE gel and transferred to a
polyvinylidene difluoride membrane (Westran clear signal;
Whatman Inc., Maidstone, UK). Membranes were then
blocked for 1 h at room temperature with Tris-buffered saline,
composed of 150 mM NaCl and 50 mM Tris, pH 7.5, and
contained 0.1% Tween (TBS-T) and 5% nonfat dry milk.
Next, membranes were probed with a polyclonal rabbit
antiserum against human KE-2 (1/4,000) [17] for 2 h in TBS-
T with 5% nonfat dry milk. A secondary horseradish
peroxydase-coupled goat antirabbit IgG (1/25,000;
Amersham Biosciences, Buckinghamshire, UK) was used for
1 h at room temperature in TBS-T with 5% nonfat dry milk.
After three washes in TBS-T, the antigen-antibody complexes
were detected by chemiluminescence using the Enhanced
Chemi Luminescence Plus (ECL+) western blotting system
(Amersham Biosciences). Results were quantified under
conditions of linearity by integration of the density of total
area of each band using a video densitometer and LabWorks
4.0 software (Media Cybernetics, Bethesda, MD). Results are
expressed as a percentage of the control optical density.
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Hematoxylin-eosin and DAPI staining of mouse eyes: Mouse
eyes (8 transgenic and 3 wild type) were dissected and fixed
in 4% paraformaldehyde for 1 h. Fixed eyes were then
embedded in 30% albumin egg, 3% gelatin (Yazzula buffer)
and frozen in liquid nitrogen to be sectioned at 14 µm with a
cryostat. Slides were rehydrated and stained with hematoxylin
for 10 min. After two washes, slides were stained with eosin
for 1 min and fixed in 50% glycerol-50% PBS.
Different slides were stained for 15 min with DAPI safe
from the light and then fixed with FluorSave. In order to
analyze similar fields, we evaluated slides on which the
optical nerve was visible on a BX51 Olympus microscope at
100X or 400X magnification. Pictures were taken using CellD
imaging software (Carl Zeiss, Jena, Germany).
Autopsy: Eight-month-old transgenic mice (two males and
two females) and wild-type (one male and one female) living
mice were sent to Frimorfo Inc. (Fribourg, Switzerland) for
an in depth analysis of all organs. This analysis includes
macroscopic inspection, necroscopy and histopathological
evaluation completed by full X-ray analysis and blood
analysis (blood chemistry and hematology).
RESULTS
Generation and validation of the transgenic model: In total,
25 independent PGK-Groenouw transgenic founders were
generated, with a transgene integration averaged ratio of 37%
±18 of the newborns, depending on the lentiviral batch and
titer. In this study, we observed that only batches of lentiviral
particles titrated above 1x108 TU/ml were effective in
generating transgenic animals. We routinely screened the
mice by PCR for transgene integration, using primers specific
for the transgene and RT–PCR for transcript expression
(Figure 2). As described in the previous section, digestion of
endogenous mouse TGFBI/BIGH3 resulted in only one band
whereas BamHI digestion of transgenic (human) TGFBI/
BIGH3 resulted in two bands.
Southern blot analyses were used to evaluate the number
of integration sites in the F1 generation of transgenic mice.
Generally one to four sites were observed (Figure 3A). Based
on the size of the fragments, and assuming no recombination
in the region of the probe, five integration sites were seen in
the Southern blot analysis of transgenic mice. It is assumed
that, with successive generations, the number of integration
sites will diminish. Moreover, localization of integration sites
were monitored in some transgenic animals using linear
amplification mediated polymerase chain reaction (LAM-
PCR) method. Integration of lentiviral vectors were seen in
chromosomes 7, 8, 14, 19, and Y. Table 2 indicates the exact
positions of the identified integration sites.
We additionally monitored tissue expression in glycerol-
embedded sectioned tissues (not shown) and by western blot
using an anti-KE2 antibody in transgenic mice expressing the
R555W mutation under the control of the PGK promoter. KE
expression was slightly increased in the retina of transgenic
mice compared to wild-type mice (Figure 3B, left panel). We
also observed a clear expression of KE in the brain of
transgenic mice, whereas no expression was found in wild-
type mice (Figure 3B). Overall, it did not seem to affect
endogenous expression in other tissues (Figure 3B, left and
right panels). The figure also showed smaller bands
corresponding to degradation products of the protein.
Organ comparisons between phosphoglycerate kinase
promoter-Groenouw transgenic and wild-type mice: The
weight of the organs of eight-month-old transgenic mice (two
males and two females) was compared to age- and sex-
matched control mice. Transgenic mice appeared to be healthy
and did not display particular abnormal behavioral signs for
up to 18 months.
Transgenic mice tended to have increased organ size and
weight, except for the thymus that was reduced in size
compared to age-matched wild-type NMRI mice (Table 3).
Transgenic female mice showed follicular hyperplasia (Figure
4, lower panel), increased amount of extramedullary
hematopoiesis, and higher spleen weights (Table 3). The
weight of the heart and kidneys was higher in transgenic
females (Table 3), but morphology was normal.
Figure 2. Screening for transgenic TGFBI/BIGH3 mRNA
expression. A: The scheme shows the difference between human and
murine TGFBI/BIGH3. Note the localization of the primers used for
the PCR and the unique BamHI site present only in the human gene.
B: Migration of undigested corneal (lanes 2 and 4) or BamHI
digested retinal (lanes 1 and 3) cDNA amplimers from two different
PGK-Groenouw transgenic mice, as showed in A. L indicates the 1-
kb DNA ladder lane.
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We did not observe other differences between males and
females for relative weight or histology of other organs,
compared to non-transgenic animals. Overall, no statistical
differences were observed in protein concentrations (Table
4A) or in cell composition (Table 4B) of blood between
transgenic mice and wild-type mice. One transgenic female
presented lipogenic pigment accumulation in the adrenal
gland.
Transgenic-dependent retinal degeneration: Transgenic
expression of KE was observed in the retina but not in the
cornea of transgenic animals. We therefore investigated the
effect of TGFBI/BIGH3 overexpression in retinal tissue.
While electroretinogram (ERG) response to increasing
intensities flashlights were normal in 2-month-old transgenic
mice, we observed a reduction in a- and b-waves in more than
50% of the older mice (Figure 5). In scotopic conditions, at
an illumination of 100 mcds/s, 2-month-old mice showed a
mean b-wave of 346 mV whereas this mean measure falls to
211 mV at 6 month. Four out six (66.7%) mice showed b-
waves even lower than the mean measure. In comparison and
in the same conditions, NMRI wild type mice showed no
difference in mean values from 2 to 6.5 month of age. Mice
Figure 3. TGFBI/BIGH3 expression analyzed by Southern and
western blots. A: The Southern blot shows various integration sites
of the transgene in 27 PGK-Groenouw F1 transgenic animals
originating from four different founders. B: The Western blot against
TGFBI/BIGH3 of the wild type (left panel) shows no expression in
the retina and the brain in comparison with the western blot of a PGK-
Groenouw transgenic mouse (right panel). The following
abbreviations are used in (B): cornea (C ), retina (R ), brain (B), heart
(H), liver (L), spleen (S), kidney (K), and muscle (M). The arrow
indicates 64 kDa band corresponding to keratoepithelin.
with flat ERG also showed a diminution of the retina thickness
and a global disorganization of the cell disposition in the retina
of transgenic mice expressing the Groenouw mutation
compared to control mice (Figure 6). Quantifications of the
outer and inner nuclear layers thickness showed a significant
diminution of each layer corresponding to a global diminution
in transgenic mice (Figure 6B).
DISCUSSION
Despite many studies on TGFBI/BIGH3 in the development
of human corneal dystrophy, its physiologic role is not yet
entirely understood. To further elucidate the function of the
gene, we generated a transgenic mouse line expressing one of
the major mutant forms of human TGFBI/BIGH3.
TGFBI/BIGH3 expression in our transgenic mouse line
showed variable transgene amount expressed in different
organs. However, our results consistently showed not only a
clear overexpression of the protein in the heart and the kidney
but a protein expression appeared in the retina and in the brain
(Figure 3). Transgene expression of human TGFBI/BIGH3
was also observed in other organs, but to a lesser extent.
TABLE 2. LOCATION OF VIRUS INTEGRATION SITES IN TRANSGENIC MICE
Chromosome Contig Position Mouse ID
7 NT_039407.1 1329488 708, 718
8 NT_081820.1 303322 705, 724
8 NT_039456.3 12023612 703, 708
718, M15
M129, M130
M139, M142
M165, M172
M176, M178
M179, M191
M196
14 NT_039606.7 34668 708
19 NT_039689.1 3483949 708
17 different mice (Mouse ID) have been submitted to linear
amplification mediated polymerase chain reaction (LAM-
PCR). Five different integration sites have been identified,
and each of them is characterized by its chromosome, its
contig and its exact position.
TABLE 3. MEAN ORGAN WEIGHT OF TRANSGENIC AND WILD-TYPE MICE.
Organ Mean weight (grams)
Transgenic (SEM) Control (SEM)
Body weight 46.65 (14.84) 38.85 (10.82)
Brain 1.21 (0.46) 1.245 (0.40)
Spleen 0.39 (0.22) 0.26 (0.07)
Liver 5.405 (1.62) 4.07 (0.30)
Left Kidney 0.94* (0.13) 0.675 (0.02)
Right Kidney 0.935* (0.10) 0.675 (0.06)
Heart 0.505 (0.12) 0.39 (0.03)
Thymus 0.06 (0.04) 0.08 (0.04)
Four transgenic and two wild-type mice were sacrificed and
weighed. SEM indicates the standard deviation observed for
each organs, and asterisk indicate significant differences
between transgenic and wild-type organ (the asterisk denotes
a p<0.05).
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Usually, viral vectors are known to randomly integrate in
the host genome. However, a report by Hacein-Bey-Abina and
colleagues [18] challenged this assumption, and the idea of
preferred integration sites for viral vectors emerged. The
integration sites varied, depending on the type of virus
implicated, and occurred within active transcription units and
more particularly, within or near genes encoding for proteins
with kinase, transferase function, or phosphorylation activity
[19,20]. As seen in Figure 3, several transgenic mice shared a
same integration site on chromosome 8 (Table 2). We didn’t
find any gene with retina-specific transcript in this region. The
technique used did not allow us to identify all integration sites,
and it is likely that other chromosomes regions harbored
Figure 4. Hyperplasia histology analysis of the spleen in a transgenic
mouse compared to a wild type mouse. Shown is a hematoxylin-eosin
coloration of spleen taken from an eight-month-old wild type (A)
mouse and an eight-month-old transgenic (B) mouse. Hyperplasia of
the folliculi in the transgenic mice can be seen in (B). Both pictures
were taken at 100X magnification.
transgenes. This is corroborated by the results of the Southern
blots showing more than two sites of integration.
Transgenic animals did not present apparent macroscopic
abnormalities compared to control mice, suggesting that KE
overexpression did not severely impair mouse development.
Previous studies showed that TGFBI/BIGH3 is involved in
cell growth, tumor genesis, wound healing, apoptosis,
migration, and osteogenesis among others [21]. This could
mean that such actions are under the control of domains not
mutated in our experiments. Results of blood analysis
suggested that no metabolic change occurred in transgenic
mice (Table 4). Moreover, no evident differences were
observed at the cellular level except for spleen follicular
hyperplasia in the transgenic female animals (Figure 4). We
did not obtain any measurable KE expression in the cornea of
transgenic animals with the promoter tested (Figure 3). This
lack of expression was not due to transcriptional silencing
since no transgene insertion was observed in DNA extracted
from corneas (Figure 2). A possible explanation could be the
TABLE 4. BLOOD CHEMISTRY AND HEMATOLOGY OF TRANSGENIC AND WILD-TYPE MICE.
A
Blood Chemistry Transgenic Control
Serum Glucose (mmol/l) 9.08 7.60
Urea (mmol/l) 11.67 9.15
Creatinine (μmol/l) 25.00 18.00
Protein (Biuret; g/l) 69.37 49.65
Albumin (g/l) 41.44 30.35
Cholesterin (mmol/l) 5.07 3.10
ASAT (GOT; U/l) 90.33 63.50
ALAT (GPT; U/l) 50.33 30.50
CK (U/l) 376.00 220.50
Amylase (U/l) 4707.27 3376.70
Calcium (mmol/l) 3.07 2.24
Phosphate (mmol/l) 2.46 1.67
Sodium (mmol/l) 209.60 156.85
Potassium (mmol/l) 6.09 4.45
B
Hematology Transgenic Control
Hematocrit (%) 0.455 0.43
Hemoglobin (g/l) 161.5 158
Erythrocytes (x1012/l) 9.53 9.32
Leukocytes (x109/l) 5 5.3
MCH (pg) 16.75 17
MCHC (g/l) 354.5 367
MCV (fl) 48 46
Thrombocytes (x109/cl) 13.96 12.45
Banded Neutrophils (%) 0.375 0.25
Segmented Neutrophils (%) 22.5 12.75
Eosinophils (%) 2.125 1.25
Monocytes (%) 1.125 1
Lymphocytes (%) 73.875 84.75
Segmented Neutrophils (x109/l) 1.2 0.71
Eosinophils (x109/l) 0.1275 0.06
Lymphocytes (x109/l) 3.5725 4.445
Blood was removed from four transgenic and two wild-type
mice. Mean measures have been measured for blood
chemistry (A) and hematology (B ) in transgenic and wild-type
mice. Abbreviations in the table: ASAT is aspartate amino
transferase; ALAT is alanine amino transferase; CK is
creatinine kinase; MCH is mean corpuscular hemoglobin;
MCHC is mean corpuscular hemoglobin concentration; MCV
is mean corpuscular volume.
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systematic elimination of corneal cells overexpressing the
transgene. Alternatively, this could be the result of an
embryonic selection of corneal cells devoid of transgene,
since we previously described that overexpression of KE
induce apoptosis in cell lines [22]. It is possible that the KE
silencing in the cornea might be consecutive to the method
used to generate transgenic animals. Such a selection process
may not be present later in life as Bainbridge et al. [7] showed
stable transgenic expression in corneal endothelium when the
transgene was directly injected in the anterior chamber. A
Figure 5. Electroretinogram analysis of transgenic mice at various
ages. A: Amplitudes of b-waves of PGK-Groenouw transgenic
mice’s electroretinogram (ERG) distributed in function of their age.
B: ERG recordings in response to single flashes in scotopic
conditions. Two different six-month-old PGK-BIG Groenouw
transgenic animals showed either a normal response (upper panel) or
a flat ERG (lower panel). Conditions: A1 to V1 shows records with
increasing intensities of light from 0.1 to 25000 mcds/m2 and each
division of the time axis correspond to 40 ms. U1 to j1 shows records
with increasing frequencies of flashlight from 0.5 to 30 Hz and each
division of the time axis correspond to 50 ms.
transgenic mouse generated with the traditional method might
also generate another expression pattern.
Interestingly, we observed an age-dependent retinal
degeneration in transgenic mice that was not seen in wild-type
controls (Figure 6). The observation was confirmed by ERG
analyses (Figure 5). Moreover, lipogenic pigments were also
observed in transgenic mice. This pigment is common in
normal aging mice, but rare before 18 months of age. The
presence of this pigment in our transgenic mice suggests an
accelerated aging process that may explain in part the retinal
degeneration. The follicular hyperplasia observed in the
spleen was found only in female mutants. Again, this finding
is relatively common in 6-month-old wild-type mice and
increases in frequency with age, which is consistent with an
accelerated aging process. A study by Kuro-o et al. [23]
described a transgenic mouse line leading to a syndrome
resembling human aging. The results showed a short lifespan,
infertility, and arteriosclerosis, among others. Interestingly,
the authors also noted a slight increase in calcium and
phosphorus in blood serum, accompanied with a diminution
Figure 6. Measurement of the outer nuclear layer of the retina in
transgenic and wild-type mice. A: Retinas of a wild type (left panel)
and of a PGK-Groenouw transgenic (right panel) mouse stained with
hematoxilin-eosin. The bars indicate the outer nuclear layer (ONL)
of the retina. The pictures were taken at a 600X magnification. B:
ONL and outer plus inner nuclear layer (INL-ONL) of retinas from
control nontransgenic (Ctl) and PGK-Groenouw transgenic (Tg)
mice at 16 months of age were measured and quantified in the graph.
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of leukocytes and lymphocytes. We also observed this
tendency in our data (Table 4) but our results are not
statistically significant (p=0.59 and 0.65 for difference in
calcium and lymphocyte concentrations respectively). This
study also noted growth retardation in transgenic mice, which
is in accordance with our results. On the other hand, Olsson
et al. [24] showed that overexpression of normal proteins can
damage photoreceptors because of protein trafficking
abnormalities. This observation may be in accordance with
the retinal degeneration observed in transgenic mice, but does
not explain the early presence of lipogenic pigment and the
follicular hyperplasia.
In conclusion, we generated a transgenic mouse line
expressing an R555W human mutated TGFBI/BIGH3.
Extensive histopathological evaluation, completed by full X-
ray and blood analysis showed no evident differences
compared to wild-type mice, except for retinal degeneration.
The transgenic mice seemed to grow quicker than wild-type
mice, as they tended to be bigger than age-matched wild-type
mice. The presence of lipogenic pigment, the retinal
degeneration, and the follicular hyperplasia of the spleen
observed in the transgenic mice suggest an accelerated aging
process.
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